This study assesses the use of non-invasive MRI to monitor evolution and treatment of Myelofibrosis (MF) in both clinical and pre-clinical settings to quantify disease progression and treatment efficacy. Based on a limited number of studies, MRI can detect changes in the bone marrow fat distribution and fibrosis caused by the progression and treatment of MF. This work seeks quantitative measures such as proton density fat fraction, magnetization transfer and diffusion weighted imaging to investigate proportions of fat, cellularity and fibrosis in bone marrow caused by MF.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords